Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Fujisawa announced setback in launch data for Protopic

Aug. 10, 1999

Patent for wound healing technology patent awarded to BioSpecifics and Tufts

Aug. 5, 1999

Oxis receives U.S. patent for lipid-soluble antioxidants for skin protection

Aug. 4, 1999

Integra LifeSciences's dural graft matrix granted 510(k) clearance by FDA

Aug. 3, 1999

Connetics seeks FDA approval of scalp dermatoses treatment

July 30, 1999

Adolor and SmithKline Beecham sign licensing agreement for ADL-2-1294

July 29, 1999

Patient enrollment completed in Anogesic phase III trial

July 27, 1999

IDE granted to Gliatech for ADCON-A

July 22, 1999

Nonsteroidal Rx for atopic dermatitis enters late-stage clinical trials in U.S.

July 13, 1999

Positive results from phase II psoriasis study of hu1124 presented at dermatology meeting

July 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...